Abstract
A method for evaluation of interferon (IFN) preparations for clinical trials is presented. IFN produced by human lymphoblastoid cells, undergoes strict quality control and safety tests, based on the U.S. Food and Drug Administration (FDA) recommendations. According to the results obtained, the IFN preparation meets the standards for use in man.
Original language | English |
---|---|
Pages (from-to) | 493-496 |
Number of pages | 4 |
Journal | Biotechnology Letters |
Volume | 5 |
Issue number | 8 |
DOIs | |
State | Published - Aug 1983 |
Externally published | Yes |